B. Maliakkal

发表

A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction

M. Koçak, D. Maluf, Simonne S. Nouer, 2020, PloS one.

Impact of Chronic Kidney Disease on Outcomes in Cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.

C. Kovesdy, M. Molnar, V. Balaraman, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Urinary organ specific neoantigen

Z. Bentwich, M. Tobi, P. Rozen, 1995, Digestive Diseases and Sciences.

Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis

A. Khorana, M. Orloff, G. Tsoulfas, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy

D. Rockey, J. Bajaj, B. Scharschmidt, 2016, Digestive Diseases and Sciences.

Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience

M. Molnar, D. Maluf, V. Mas, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.

T. Hassanein, P. Kwo, E. Gane, 2016, Gastroenterology.

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis.

T. Hassanein, G. Dore, P. Kwo, 2017, Journal of hepatology.

Cellular distribution of a colonic adenoma-associated antigen as defined by monoclonal antibody Adnab-9.

M. Tobi, S. Fligiel, J. Hatfield, 1992, Scandinavian journal of gastroenterology.

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Manfred von der Ohe, A. Coates, C. Trautwein, 2019, The Lancet.

Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.

Pradeep S B Podila, S. Satapathy, Hemnishil K Marella, 2020, Journal of clinical and experimental hepatology.

African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians.

Pradeep S B Podila, S. Satapathy, Hemnishil K Marella, 2020, European journal of gastroenterology & hepatology.

Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis.

K. Reddy, P. Kamath, P. Thuluvath, 2019, The American journal of gastroenterology.

Zollinger-Ellison syndrome, acromegaly, and colorectal neoplasia.

A. Cats, M. Tobi, R. Dullaart, 1997, Journal of clinical gastroenterology.

Acute Hepatitis A Causing Severe Hemolysis and Renal Failure in Undiagnosed Glucose-6-Phosphate Dehydrogenase Deficient Patient: A Case Report and Review of the Literature

Bilal Ali, R. Jain, S. Nair, 2021, Case reports in hepatology.

Omeprazole inhibits growth of cancer cell line of colonic origin

M. Tobi, K. Öberg, M. Lundqvist, 1995, Digestive Diseases and Sciences.

Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes

K. Reddy, P. Kamath, P. Thuluvath, 2017, The American Journal of Gastroenterology.

New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.

K. Reddy, P. Kamath, M. Fallon, 2013, Gastroenterology.

Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis.

Michael E. Kader, P. Mantry, B. Maliakkal, 2009, World journal of gastroenterology.

Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.

Krishnakant V. Saboo, Chang Hu, K. Reddy, 2020, The American journal of gastroenterology.

Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi‐centre cohort

K. Reddy, P. Kamath, P. Thuluvath, 2019, Alimentary pharmacology & therapeutics.

Outcomes After Listing for Liver Transplant in Patients With Acute‐on‐Chronic Liver Failure: The Multicenter North American Consortium for the Study of End‐Stage Liver Disease Experience

K. Reddy, P. Kamath, P. Thuluvath, 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis

K. Reddy, P. Kamath, P. Thuluvath, 2019, The American journal of gastroenterology.

Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort

K. Reddy, P. Kamath, P. Thuluvath, 2017, The American Journal of Gastroenterology.

Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures

P. Kamath, P. Thuluvath, S. Biggins, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Living Donor and Deceased Donor Liver Transplantation for Autoimmune and Cholestatic Liver Diseases—An Analysis of the UNOS Database

Rajeev Sharma, M. Orloff, C. Ryan, 2010, Journal of Gastrointestinal Surgery.

Comparative Analysis of Outcomes in Living and Deceased Donor Liver Transplants for Primary Sclerosing Cholangitis

Rajeev Sharma, M. Orloff, C. Ryan, 2009, Journal of Gastrointestinal Surgery.

Short communication: risk of elevated total cholesterol/high-density lipoprotein cholesterol ratio after antiretroviral therapy in HIV/hepatitis C virus patients.

S. Fisher, S. Cohn, M. J. Adams, 2012, AIDS research and human retroviruses.

Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study

M. Molnar, Pradeep S B Podila, S. Nair, 2020, Transplantation direct.

Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease

A. Singal, G. Cholankeril, Pradeep S B Podila, 2020, Clinical and translational gastroenterology.

Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature.

A. Nawras, M. Alsolaiman, S. Mehboob, 2002, Digestive diseases and sciences.

Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infection.

B. Maliakkal, K. Soota, 2014, World journal of gastroenterology.

Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.

K. Reddy, D. Nelson, S. Gordon, 2015, Journal of hepatology.

Transplantation of liver from hepatitis C–infected donors to hepatitis C RNA–negative recipients: Histological and virologic outcome

M. Molnar, Bilal Ali, R. Jain, 2021, Clinical transplantation.

Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

B. Maliakkal, 2020, Translational gastroenterology and hepatology.

Lack of Association between Pretransplant Donor-Specific Antibodies and Posttransplant Kidney Outcomes in Simultaneous Liver-Kidney Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Steroid-Free Protocol

C. Kovesdy, M. Molnar, V. Balaraman, 2020, Nephron.

Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial

T. Hassanein, T. Pilot‐Matias, P. Kwo, 2018, Hepatology.

Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population

S. Fisher, S. Cohn, M. J. Adams, 2013, International journal of clinical practice.

CASE REPORT: Systemic Sarcoidosis Presenting as a Granulomatous Tattoo Reaction Secondary to Interferon-α Treatment for Chronic Hepatitis C and Review of the Literature

A. Nawras, M. Alsolaiman, S. Mehboob, 2002, Digestive Diseases and Sciences.

Colovesical Fistula Complicating the First Symptomatic Episode of Acute Diverticulitis in a Young Adult

B. Maliakkal, Rabira R Dufera, Oluwaremilekun Tolu-Akinnawo, 2023, Cureus.

Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study.

E. Gane, D. Brainard, R. Robson, 2020, The lancet. Gastroenterology & hepatology.

The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2016, Hepatology.

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

D. Gerding, Wayne N. Campbell, J. Zenilman, 2017, The Lancet. Infectious diseases.

Adenoma-derived antibody, Adnab-9 recognizes a membrane-bound glycoprotein in colonic tissue and effluent material from patients with colorectal neoplasia.

M. Tobi, L. Nochomovitz, G. Luk, 1992, Cancer letters.

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation

Andrew A. Li, G. Cholankeril, Donghee Kim, 2019, Scientific Reports.

Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax

P. Kamath, P. Thuluvath, S. Biggins, 2020, Digestive Diseases and Sciences.

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics.

P. Kwo, W. Kraft, M. Sulkowski, 2013, Antiviral research.

Budd-Chiari Syndrome as an Initial Presentation of Non-Promyelocytic Acute Myelogenous Leukemia

W. Angel, J. Kothadia, B. Maliakkal, 2022, Gastroenterology research.

Nutrition in Chronic Liver Disease

Uchenna Agbim, B. Maliakkal, Y. K. Reddy, 2019, Current Treatment Options in Gastroenterology.

Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox

V. Wong, P. Thuluvath, R. Maiwall, 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Bouveret's syndrome complicated by distal gallstone ileus after laser lithotropsy using Holmium: YAG laser

A. Nawras, M. Alsolaiman, J. Rodgers, 2002, BMC gastroenterology.

Bouveret's syndrome complicated by distal gallstone ileus after laser lithotripsy

A. Nawras, J. Rodgers, B. Maliakkal, 2000, American Journal of Gastroenterology.

GS-02-Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial

Michael I. Miller, R. Andrade, F. Nevens, 2019, Journal of Hepatology.

Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures

K. Reddy, P. Kamath, S. Biggins, 2014, Hepatology.

100% SVR4 with ABT-493 and ABT-530 with or without Ribavirin in Treatment-Naïve HCV Genotype 3-Infected Patients with Cirrhosis

P. Kwo, M. Shiffman, E. Gane, 2016 .

Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients

M. Molnar, V. Balaraman, Pradeep S B Podila, 2020, Renal failure.

A Karnofsky performance status–based score predicts death after hospital discharge in patients with cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2017, Hepatology.

Insurance Status but Not Race/Ethnicity are Associated with Outcomes in a Large Hospitalized Cohort of Patients with Cirrhosis.

K. Reddy, P. Kamath, P. Thuluvath, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience

K. Reddy, P. Kamath, P. Thuluvath, 2020, Digestive Diseases and Sciences.

NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2018, Hepatology.

Urinary organ specific neoantigen. A potentially diagnostic test for colorectal cancer.

Z. Bentwich, M. Tobi, P. Rozen, 1995, Digestive Diseases and Sciences.

The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis

P. Kamath, P. Thuluvath, S. Biggins, 2018, The American Journal of Gastroenterology.

Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experience

Rajeev Sharma, M. Orloff, C. Ryan, 2010, Clinical transplantation.

Hyperammonemic encephalopathy associated with 5-fluorouracil in a patient with previous orthotopic liver transplantation

S. Nair, Amit L. Jain, Uchenna Agbim, 2020, Proceedings.

Safety and efficacy of treatment with once-daily ledipasvir/sofosbuvir (90/400 mg) for 12 weeks in genotype 1 hcv-infected patients with severe renal impairment.

E. Gane, D. Brainard, J. McHutchison, 2017 .

Progression of Stage 2 and 3 Acute Kidney Injury in Patients with Decompensated Cirrhosis and Ascites.

K. Reddy, P. Kamath, P. Thuluvath, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience

K. Reddy, P. Kamath, S. Biggins, 2017, Digestive Diseases and Sciences.

Polypoid rectal mass in a 21-year-old woman with hematochezia.

B. Maliakkal, Rajiv Sharma, 2011, Gastroenterology.

Prognosis of hospitalized patients with cirrhosis and acute kidney disease

K. Reddy, P. Kamath, P. Thuluvath, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis Running head : Short-term mortality after discharge from hospital in cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2016 .

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation

Andrew A. Li, G. Cholankeril, Donghee Kim, 2019, Scientific Reports.

Fish oil dietary supplementation for prevention of indomethacin induced gastric and small bowel toxicity in healthy volunteers.

J. Kremer, J. Cooper, J. Rodgers, 1996, Journal of Rheumatology.